tiprankstipranks
Trending News
More News >
Biodexa Pharmaceuticals (BDRX)
NASDAQ:BDRX
Advertisement

Biodexa Pharmaceuticals (BDRX) Price & Analysis

Compare
505 Followers

BDRX Stock Chart & Stats


Biodexa Pharmaceuticals News

BDRX FAQ

What was Biodexa Pharmaceuticals’s price range in the past 12 months?
Biodexa Pharmaceuticals lowest stock price was $0.78 and its highest was $17.88 in the past 12 months.
    What is Biodexa Pharmaceuticals’s market cap?
    Biodexa Pharmaceuticals’s market cap is $588.36K.
      When is Biodexa Pharmaceuticals’s upcoming earnings report date?
      Biodexa Pharmaceuticals’s upcoming earnings report date is Sep 11, 2025 which is in 43 days.
        How were Biodexa Pharmaceuticals’s earnings last quarter?
        Biodexa Pharmaceuticals released its earnings results on Apr 11, 2025. The company reported -$0.001 earnings per share for the quarter, the consensus estimate of -$0.001 by $0.
          Is Biodexa Pharmaceuticals overvalued?
          According to Wall Street analysts Biodexa Pharmaceuticals’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
            Does Biodexa Pharmaceuticals pay dividends?
            Biodexa Pharmaceuticals does not currently pay dividends.
            What is Biodexa Pharmaceuticals’s EPS estimate?
            Biodexa Pharmaceuticals’s EPS estimate is 0.
              How many shares outstanding does Biodexa Pharmaceuticals have?
              Biodexa Pharmaceuticals has 5,050,631 shares outstanding.
                What happened to Biodexa Pharmaceuticals’s price movement after its last earnings report?
                Biodexa Pharmaceuticals reported an EPS of -$0.001 in its last earnings report, expectations of -$0.001. Following the earnings report the stock price went up 12.739%.
                  Which hedge fund is a major shareholder of Biodexa Pharmaceuticals?
                  Currently, no hedge funds are holding shares in BDRX

                  Company Description

                  Biodexa Pharmaceuticals

                  Biodexa Pharmaceuticals Plc, a drug delivery technology company, focuses on the bio-delivery and biodistribution of medicines in Belgium and internationally. The company is developing MTX110, a direct delivery treatment for diffuse intrinsic pontine glioma, medulloblastomas, and glioblastoma multiforme; MTD211, a long-acting formulation of brexpiprazole for the treatment of schizophrenia and adjunctive treatment of major depressive disorder; and MTX223, a long-acting injectable formulations of biologic products, such as mAbs or other high molecular weight proteins. It also offers drug delivery platforms, such as Q-Sphera, a polymer microsphere microtechnology used for sustained release drug delivery; MidaSolve, an oligosaccharide nanotechnology used to solubilize drugs so that they can be administered in liquid form directly and locally into tumors; and MidaCore, a gold nanoparticle used for targeting sites of disease by using chemotherapeutic agents or immunotherapeutic agents. The company was formerly known as Midatech Pharma plc and changed its name to Biodexa Pharmaceuticals Plc in March 2023. Biodexa Pharmaceuticals Plc was founded in 2000 and is headquartered in Cardiff, the United Kingdom.

                  Biodexa Pharmaceuticals (BDRX) Earnings & Revenues

                  Similar Stocks
                  Company
                  Price & Change
                  Follow
                  Kazia Therapeutics
                  Oragenics
                  Xenetic Biosciences
                  NLS Pharmaceutics
                  Pasithea Therapeutics Corp

                  Ownership Overview

                  1.87%<0.01%<0.01%98.13%
                  1.87%
                  Insiders
                  <0.01% Other Institutional Investors
                  98.13% Public Companies and
                  Individual Investors

                  Options Prices

                  Currently, No data available
                  ---
                  Popular Stocks
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis